Non-ST-elevation acute coronary syndrome (NSTE-ACS) assigns to a range of acute conditions resisting acute myocardial ischemia and infarctions that are common because of a sudden decrease in myocardial coronary blood flow.
Refractory hypertension (RfHTN) is a phenotype of antihypertensive therapy failure described as uncontrolled BP (≥130/80 mm Hg), regardless of adequate doses of 5 or more different classes of antihypertensive medications incorporating a long-acting thiazide-like diuretic (chlorthalidone) and a mineralocorticoid receptor antagonist (MRA).
Non-invasive imaging in the PESA (Progression of Early Subclinical Atherosclerosis) study revealed that 71% and 43% of middle-aged men and women, respectively, have evidence of subclinical atherosclerosis.
A coronary artery disease (CAD) responsiveness is focused on chromosome 15q26.1, recognized by genome-wide association studies.
ESH Congress was held from June 21-24th, 2019 in Milan, Italy. The ESH is a stable and organised European platform for scientific exchange in hypertension. Carbon Brand Solutions was indeed fortunate to attend and cover the exciting live sessions and interview some of the KOL’s who threw significant light on the different aspects of hypertension.
